Guanonisa reduz a neurotoxicidade e o déficit motor induzido pelo traumatismo cranioencefálico em ratos

Detalhes bibliográficos
Autor(a) principal: Gerbatin, Rogério da Rosa
Data de Publicação: 2016
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Manancial - Repositório Digital da UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/18024
Resumo: Traumatic brain injury (TBI) affects annually 10 million of people causing neurological symptoms and deaths resulting in an adverse socio-economic impact worldwide. The pathophysiology of TBI comprises multiple neurotoxic processes, such as excitotoxicity, mitochondrial dysfunction and inflammation leading to neuronal death and consequently clinical manifestations, as motor deficit. Many studies with promising drugs in experimental models of TBI reported failures in clinical tests, so it is important to search for new therapeutic drugs. Currently, much attention has been devoted to the neuroprotective effects of guanosine, an endogenous nucleoside able to reduce neurotoxic events in experimental models of ischemia in vivo and in vitro, which to our knowledge has not yet been evaluated in the TBI. Therefore, the present study evaluated the therapeutic potential of guanosine in locomotor impairment and neurodegeneration after TBI by controlling excitotoxicity, mitochondrial and inflammatory alterations. Male Wistar rats were subjected to TBI by moderate fluid percussion injury (PFS) parasagittal model and 40 minutes after was administered guanosine (7.5mg / kg intraperitoneally). Our results show that guanosine protects against the locomotor deficit induced by TBI 8 hours after the insult. Similarly, guanosine was also able to protect against the neurochemical damage in the ipsilateral cortex characterized by the inhibition of glutamate uptake, Na+, K+ - ATPase and glutamine synthetase activity , alterations in mitochondrial membrane potential (ΔѰm) followed by an increase in production of reactive species oxygen (ROS) and content of protein carbonyls. Furthermore, the inflammatory response induced by TBI evidenced by increased levels of TNF-α, IL-1β and cerebral edema was also reduced by guanosine. In addition to these findings, guanosine protected against the neuronal death and activation of caspase 3, reinforcing its neuroprotective effects. Thus, our study represents an important contribution to the knowledge of the neuroprotective effects of guanosine in the TBI, making this an attractive candidate molecule for the treatment of this insult, although more studies are needed to clarify their potential in clinical TBI.
id UFSM_3e3cc4fa842524d2575a5d79261c58a7
oai_identifier_str oai:repositorio.ufsm.br:1/18024
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Guanonisa reduz a neurotoxicidade e o déficit motor induzido pelo traumatismo cranioencefálico em ratosGuanosine reduces the neurotoxicity and the motor deficit induced by traumatic brain injury in ratsTraumatismo cranioencefálicoExitotoxicidadeMitocôndriaInflamaçãoDéficit motorGuanosinaRatosTraumatic brain injuryExitotoxicityMitochondriaInflammationMotor deficitGuanosineRatsCNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICATraumatic brain injury (TBI) affects annually 10 million of people causing neurological symptoms and deaths resulting in an adverse socio-economic impact worldwide. The pathophysiology of TBI comprises multiple neurotoxic processes, such as excitotoxicity, mitochondrial dysfunction and inflammation leading to neuronal death and consequently clinical manifestations, as motor deficit. Many studies with promising drugs in experimental models of TBI reported failures in clinical tests, so it is important to search for new therapeutic drugs. Currently, much attention has been devoted to the neuroprotective effects of guanosine, an endogenous nucleoside able to reduce neurotoxic events in experimental models of ischemia in vivo and in vitro, which to our knowledge has not yet been evaluated in the TBI. Therefore, the present study evaluated the therapeutic potential of guanosine in locomotor impairment and neurodegeneration after TBI by controlling excitotoxicity, mitochondrial and inflammatory alterations. Male Wistar rats were subjected to TBI by moderate fluid percussion injury (PFS) parasagittal model and 40 minutes after was administered guanosine (7.5mg / kg intraperitoneally). Our results show that guanosine protects against the locomotor deficit induced by TBI 8 hours after the insult. Similarly, guanosine was also able to protect against the neurochemical damage in the ipsilateral cortex characterized by the inhibition of glutamate uptake, Na+, K+ - ATPase and glutamine synthetase activity , alterations in mitochondrial membrane potential (ΔѰm) followed by an increase in production of reactive species oxygen (ROS) and content of protein carbonyls. Furthermore, the inflammatory response induced by TBI evidenced by increased levels of TNF-α, IL-1β and cerebral edema was also reduced by guanosine. In addition to these findings, guanosine protected against the neuronal death and activation of caspase 3, reinforcing its neuroprotective effects. Thus, our study represents an important contribution to the knowledge of the neuroprotective effects of guanosine in the TBI, making this an attractive candidate molecule for the treatment of this insult, although more studies are needed to clarify their potential in clinical TBI.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESO traumatismo cranioencefálico (TCE) afeta anualmente 10 milhões de pessoas ocasionando mortes e sintomas neurológicos que resultam em um impacto socioeconômico desfavorável a nível mundial. Sua fisiopatologia compreende múltiplos processos neurotóxicos, tais como a excitotoxicidade, disfunção mitocondrial e inflamação que conduzem a morte neuronal e, consequentemente a manifestações clínicas, como o déficit motor. Muitos estudos com drogas promissoras em modelos experimentais de TCE reportaram falhas quando testadas clinicamente, assim torna-se importante à busca por novas drogas terapêuticas. Atualmente, muita atenção tem sido dedicada aos efeitos neuroprotetores da guanosina, um nucleosídeo endógeno capaz de reduzir eventos neurotóxicos em modelos experimentais de isquemia in vivo e in vitro, que ao nosso conhecimento, ainda não foi avaliada no TCE. Portanto, o presente estudo avaliou o potencial terapêutico da guanosina no prejuízo locomotor e neurodegeneração após o TCE por controlar a excitotoxicidade, alterações mitocondriais e inflamatórias. Ratos Wistar machos foram submetidos ao TCE pelo modelo de lesão por percussão de fluido sagital (PFS) e 40 minutos após foi administrado guanosina na dose 7.5mg/kg via intraperitoneal ( i.p). Nossos resultados revelam que a guanosina protege contra o prejuízo locomotor induzido pelo PFS 8 horas após o insulto. Do mesmo modo, a guanosina também foi capaz de proteger contra o dano neuroquímico no córtex ipsilateral caracterizado pela inibição da captação de glutamato, Na+, K+ - ATPase e glutamina sintetase, alterações do potencial de membrana mitocondrial (ΔѰm) seguido pela produção de espécies reativas de oxigênio (ERO) e aumento no conteúdo de proteínas carboniladas. De forma semelhante, a resposta inflamatória induzida pelo PFS evidenciada pelo aumento nos níveis de TNF- α, IL-1β e edema cerebral também foi reduzida por esse nucleosídeo. Além destas descobertas, a guanosina protegeu contra a morte neuronal e ativação da caspase 3, reforçando seus efeitos neuroprotetores. Dessa forma, o nosso estudo representa uma importante contribuição para o conhecimento dos efeitos neuroprotetores da guanosina no TCE, tornando esta molécula uma atraente candidata para o tratamento desse insulto, embora mais estudos sejam necessários para esclarecer o seu potencial clinico no TCE.Universidade Federal de Santa MariaBrasilBioquímicaUFSMPrograma de Pós-Graduação em Ciências Biológicas: Bioquímica ToxicológicaCentro de Ciências Naturais e ExatasRoyes, Luiz Fernando Freirehttp://lattes.cnpq.br/0543081555633400Puntel, Gustavo Orionehttp://lattes.cnpq.br/0319301096075015Gerbatin, Rogério da Rosa2019-08-26T18:45:44Z2019-08-26T18:45:44Z2016-01-29info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/18024porAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2019-08-27T06:00:37Zoai:repositorio.ufsm.br:1/18024Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2019-08-27T06:00:37Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Guanonisa reduz a neurotoxicidade e o déficit motor induzido pelo traumatismo cranioencefálico em ratos
Guanosine reduces the neurotoxicity and the motor deficit induced by traumatic brain injury in rats
title Guanonisa reduz a neurotoxicidade e o déficit motor induzido pelo traumatismo cranioencefálico em ratos
spellingShingle Guanonisa reduz a neurotoxicidade e o déficit motor induzido pelo traumatismo cranioencefálico em ratos
Gerbatin, Rogério da Rosa
Traumatismo cranioencefálico
Exitotoxicidade
Mitocôndria
Inflamação
Déficit motor
Guanosina
Ratos
Traumatic brain injury
Exitotoxicity
Mitochondria
Inflammation
Motor deficit
Guanosine
Rats
CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA
title_short Guanonisa reduz a neurotoxicidade e o déficit motor induzido pelo traumatismo cranioencefálico em ratos
title_full Guanonisa reduz a neurotoxicidade e o déficit motor induzido pelo traumatismo cranioencefálico em ratos
title_fullStr Guanonisa reduz a neurotoxicidade e o déficit motor induzido pelo traumatismo cranioencefálico em ratos
title_full_unstemmed Guanonisa reduz a neurotoxicidade e o déficit motor induzido pelo traumatismo cranioencefálico em ratos
title_sort Guanonisa reduz a neurotoxicidade e o déficit motor induzido pelo traumatismo cranioencefálico em ratos
author Gerbatin, Rogério da Rosa
author_facet Gerbatin, Rogério da Rosa
author_role author
dc.contributor.none.fl_str_mv Royes, Luiz Fernando Freire
http://lattes.cnpq.br/0543081555633400
Puntel, Gustavo Orione
http://lattes.cnpq.br/0319301096075015
dc.contributor.author.fl_str_mv Gerbatin, Rogério da Rosa
dc.subject.por.fl_str_mv Traumatismo cranioencefálico
Exitotoxicidade
Mitocôndria
Inflamação
Déficit motor
Guanosina
Ratos
Traumatic brain injury
Exitotoxicity
Mitochondria
Inflammation
Motor deficit
Guanosine
Rats
CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA
topic Traumatismo cranioencefálico
Exitotoxicidade
Mitocôndria
Inflamação
Déficit motor
Guanosina
Ratos
Traumatic brain injury
Exitotoxicity
Mitochondria
Inflammation
Motor deficit
Guanosine
Rats
CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA
description Traumatic brain injury (TBI) affects annually 10 million of people causing neurological symptoms and deaths resulting in an adverse socio-economic impact worldwide. The pathophysiology of TBI comprises multiple neurotoxic processes, such as excitotoxicity, mitochondrial dysfunction and inflammation leading to neuronal death and consequently clinical manifestations, as motor deficit. Many studies with promising drugs in experimental models of TBI reported failures in clinical tests, so it is important to search for new therapeutic drugs. Currently, much attention has been devoted to the neuroprotective effects of guanosine, an endogenous nucleoside able to reduce neurotoxic events in experimental models of ischemia in vivo and in vitro, which to our knowledge has not yet been evaluated in the TBI. Therefore, the present study evaluated the therapeutic potential of guanosine in locomotor impairment and neurodegeneration after TBI by controlling excitotoxicity, mitochondrial and inflammatory alterations. Male Wistar rats were subjected to TBI by moderate fluid percussion injury (PFS) parasagittal model and 40 minutes after was administered guanosine (7.5mg / kg intraperitoneally). Our results show that guanosine protects against the locomotor deficit induced by TBI 8 hours after the insult. Similarly, guanosine was also able to protect against the neurochemical damage in the ipsilateral cortex characterized by the inhibition of glutamate uptake, Na+, K+ - ATPase and glutamine synthetase activity , alterations in mitochondrial membrane potential (ΔѰm) followed by an increase in production of reactive species oxygen (ROS) and content of protein carbonyls. Furthermore, the inflammatory response induced by TBI evidenced by increased levels of TNF-α, IL-1β and cerebral edema was also reduced by guanosine. In addition to these findings, guanosine protected against the neuronal death and activation of caspase 3, reinforcing its neuroprotective effects. Thus, our study represents an important contribution to the knowledge of the neuroprotective effects of guanosine in the TBI, making this an attractive candidate molecule for the treatment of this insult, although more studies are needed to clarify their potential in clinical TBI.
publishDate 2016
dc.date.none.fl_str_mv 2016-01-29
2019-08-26T18:45:44Z
2019-08-26T18:45:44Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/18024
url http://repositorio.ufsm.br/handle/1/18024
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Bioquímica
UFSM
Programa de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica
Centro de Ciências Naturais e Exatas
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Bioquímica
UFSM
Programa de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica
Centro de Ciências Naturais e Exatas
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1805922030238826496